Literature DB >> 25768835

Time above 1500 copies: a viral load measure for assessing transmission risk of HIV-positive patients in care.

Gary Marks1, Lytt I Gardner, Charles E Rose, Anne Zinski, Richard D Moore, Susan Holman, Allan E Rodriguez, Meg Sullivan, Thomas P Giordano.   

Abstract

OBJECTIVE: We examined HIV transmission potential of patients in care by analyzing the amount of person-time spent above a viral load threshold that increases risk for transmission.
DESIGN: Observational cohort and supplemental data.
METHODS: The cohort included HIV patients who received care at six HIV clinics in the United States, from 1 April 2009 to 31 March 2013, and had two or more viral load tests during this interval. Person-time (in days) above a viral load of 1500 copies/ml out of the total observation time was determined by inspecting consecutive pairs of viral load results and the time intervals between those pairs. The person-time rate ratios comparing demographic and clinical subgroups were estimated with Poisson regression.
RESULTS: The cohort included 14 532 patients observed for a median of 1073 days with a median of nine viral load records. Ninety percent of the patients had been prescribed antiretroviral therapy. On average, viral load exceeded 1500 copies/ml during 23% of the patients' observation time (average of 84 days per year, per patient). Percentage of person-time above the threshold was higher among patients who had more than a fourth of their viral load pairs exceeding a 6-month interval (34% of observation time), patients not on antiretroviral therapy (58% of time), new/re-engaging patients (34% of time), patients 16-39 years of age (32% of time), and patients of black race (26% of time).
CONCLUSION: HIV patients in care spent an average of nearly a quarter of their time with viral loads above 1500 copies/ml, higher among some subgroups, placing them at risk for potentially transmitting HIV to others.

Entities:  

Mesh:

Year:  2015        PMID: 25768835      PMCID: PMC4964849          DOI: 10.1097/QAD.0000000000000640

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  16 in total

1.  The clinical interpretation of viral blips in HIV patients receiving antiviral treatment: are we ready to infer poor adherence?

Authors:  Isaac C H Fung; Manoj Gambhir; Ard van Sighem; Frank de Wolf; Geoffrey P Garnett
Journal:  J Acquir Immune Defic Syndr       Date:  2012-05-01       Impact factor: 3.731

2.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

3.  A low-effort, clinic-wide intervention improves attendance for HIV primary care.

Authors:  Lytt I Gardner; Gary Marks; Jason A Craw; Tracey E Wilson; Mari-Lynn Drainoni; Richard D Moore; Michael J Mugavero; Allan E Rodriguez; Lucy A Bradley-Springer; Susan Holman; Jeanne C Keruly; Meg Sullivan; Paul R Skolnik; Faye Malitz; Lisa R Metsch; James L Raper; Thomas P Giordano
Journal:  Clin Infect Dis       Date:  2012-07-24       Impact factor: 9.079

4.  Vital signs: HIV prevention through care and treatment--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-02       Impact factor: 17.586

5.  Increase in newly diagnosed HIV infections among young black men who have sex with men--Milwaukee County, Wisconsin, 1999-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-02-04       Impact factor: 17.586

6.  Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis.

Authors:  Gary Marks; Lytt I Gardner; Jason Craw; Nicole Crepaz
Journal:  AIDS       Date:  2010-11-13       Impact factor: 4.177

7.  Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand.

Authors:  Sodsai Tovanabutra; Valerie Robison; Jeerang Wongtrakul; Supaluk Sennum; Vinai Suriyanon; Duangnapa Kingkeow; Surinda Kawichai; Praijitr Tanan; Ann Duerr; Kenrad E Nelson
Journal:  J Acquir Immune Defic Syndr       Date:  2002-03-01       Impact factor: 3.731

Review 8.  Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis.

Authors:  Suzanna Attia; Matthias Egger; Monika Müller; Marcel Zwahlen; Nicola Low
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

9.  Short communication: HIV blips while on antiretroviral therapy can indicate consistently detectable viral levels due to assay underreporting.

Authors:  John M Murray; John J Zaunders; Kersten K Koelsch; Ven Natarajan; Yunden Badralmaa; Kristin McBride; Alexander Carrera; David A Cooper; Sean Emery; Anthony D Kelleher
Journal:  AIDS Res Hum Retroviruses       Date:  2013-08-09       Impact factor: 2.205

10.  Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011.

Authors:  Heather Bradley; H Irene Hall; Richard J Wolitski; Michelle M Van Handel; Amy E Stone; Michael LaFlam; Jacek Skarbinski; Darrel H Higa; Joseph Prejean; Emma L Frazier; Roshni Patel; Ping Huang; Qian An; Ruiguang Song; Tian Tang; Linda A Valleroy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-11-28       Impact factor: 17.586

View more
  31 in total

1.  Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012-2013.

Authors:  Nicole Crepaz; Tian Tang; Gary Marks; Michael J Mugavero; Lorena Espinoza; H Irene Hall
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

2.  Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.

Authors:  Mary Clare Kennedy; Thomas H Kerr; Evan Wood; Jeannie A Shoveller; Julio S G Montaner; M-J S Milloy
Journal:  AIDS       Date:  2018-05-15       Impact factor: 4.177

3.  Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure.

Authors:  Suzanne M McCluskey; Yap Boum; Nicholas Musinguzi; Jessica E Haberer; Jeffrey N Martin; Peter W Hunt; Vincent C Marconi; David R Bangsberg; Mark J Siedner
Journal:  J Acquir Immune Defic Syndr       Date:  2017-10-01       Impact factor: 3.731

4.  Machine Learning Analysis Reveals Novel Neuroimaging and Clinical Signatures of Frailty in HIV.

Authors:  Robert H Paul; Kyu S Cho; Patrick Luckett; Jeremy F Strain; Andrew C Belden; Jacob D Bolzenius; Jaimie Navid; Paola M Garcia-Egan; Sarah A Cooley; Julie K Wisch; Anna H Boerwinkle; Dimitre Tomov; Abel Obosi; Julie A Mannarino; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2020-08-01       Impact factor: 3.731

5.  Stimulant Use and Study Protocol Completion: Assessing the Ability of Men Who Have Sex with Men to Collect Dried Blood Spots for Laboratory Measurement of HIV Viral Load.

Authors:  Richard A Teran; Adam W Carrico; Keith J Horvath; Martin J Downing; Mary Ann Chiasson; Suzan M Walters; Sabina Hirshfield
Journal:  Arch Sex Behav       Date:  2019-10-19

6.  Pharmacologic Treatment of Psychiatric Disorders and Time With Unsuppressed HIV Viral Load in a Clinical HIV Cohort.

Authors:  Matthew E Levy; Anne K Monroe; Michael A Horberg; Debra A Benator; Sherry Molock; Rupali K Doshi; Lindsey Powers Happ; Amanda D Castel
Journal:  J Acquir Immune Defic Syndr       Date:  2019-11-01       Impact factor: 3.731

7.  Maximizing the Benefits of HIV Preexposure Prophylaxis.

Authors:  Susan P Buchbinder
Journal:  Top Antivir Med       Date:  2018-04

8.  Gaps Along the HIV Care Continuum: Findings Among a Population Seeking Sexual Health Care Services in New York City.

Authors:  Preeti Pathela; Kelly Jamison; Sarah L Braunstein; Julia A Schillinger; Olga Tymejczyk; Denis Nash
Journal:  J Acquir Immune Defic Syndr       Date:  2018-07-01       Impact factor: 3.731

9.  Characterising HIV transmission risk among US patients with HIV in care: a cross-sectional study of sexual risk behaviour among individuals with viral load above 1500 copies/mL.

Authors:  Michael J Stirratt; Gary Marks; Christine O'Daniels; Edward R Cachay; Meg Sullivan; Michael J Mugavero; Shireesha Dhanireddy; Allan E Rodriguez; Thomas P Giordano
Journal:  Sex Transm Infect       Date:  2017-11-02       Impact factor: 3.519

10.  Virologic suppression and CD4+ cell count recovery after initiation of raltegravir or efavirenz-containing HIV treatment regimens.

Authors:  Jessie K Edwards; Stephen R Cole; H Irene Hall; W Christopher Mathews; Richard D Moore; Michael J Mugavero; Joseph J Eron
Journal:  AIDS       Date:  2018-01-14       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.